マーケットレポート詳細
マイクロカテーテルの世界市場：2027年に至る製品別、用途別予測
Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年11月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文165ページになります。
- 商品コード：MAM3117
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
マイクロカテーテルの世界市場規模は2022年で8億2800万ドル、2027年に10億8200万ドルとなる見込みで、市場の平均年成長率は5.5%に上ると予想されています。
レポートはマイクロカテーテルの世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、製品デザイン別市場、等）を中心に構成されています。また競合状況、主要企業情報（25社）、市場ダイナミクス、バリューチェーン分析などの分析も加味し、マイクロカテーテル市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆マイクロカテーテルの世界市場予測2020-2027年
・市場規模(US$)
◆製品別、市場-2027年
・デリバリーマイクロカテーテル
・アスピレーションマイクロカテーテル
・診断用マイクロカテーテル
・可変マイクロカテーテル
※(市場規模US$)
◆製品デザイン別、市場-2027年
・シングルルーメンマイクロカテーテル
・デュアルルーメンマイクロカテーテル
※(市場規模US$)
◆用途別、市場-2027年
・心臓血管
・脳内血管
・末梢血管
・腫瘍
※(市場規模US$)
◆エンドユーザー別、市場-2027年
・病院、外科センター、専門クリニック
・外来診療センター
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国
・その他アジア太平洋
中南米
中東アフリカ
※地域別に各セグメント別の細分化データ掲載、詳細は目次参照
※国別に製品別の細分化データ掲載
◆市場分析
・市場ダイナミクス(促進要因、障壁、機会、課題)
・キーステークホルダー、購買基準
・業界構造分析(ファイブフォース分析)
・規制分析
・エコシステム分析
・バリューチェーン分析
・サプライチェーン分析
・貿易分析
・競合状況
◆マイクロカテーテルの主要企業プロフィール動向
・BOSTON SCIENTIFIC CORPORATION
・朝日インテック株式会社
・MEDTRONIC PLC
・STRYKER
・BECTON, DICKINSON AND COMPANY
・TERUMO MEDICAL CORPORATION
・MERIT MEDICAL SYSTEMS, INC
・CARDINAL HEALTH
・B BRAUN MELSUNGEN AG
・TELEFLEX
・JOHNSON & JOHNSON
・ANGIODYNAMICS
・PENUMBRA
・BTG PLC
・GUERBET LLC
・EMBOLX INC
・株式会社東海メディカルプロダクツ
・株式会社カネカ
・INTEGER HOLDINGS CORPORATION
・リバテープ製薬株式会社
・MICROVENTION TERUMO
・REFLOW MEDICAL
・SPARTAN MICRO
・TRANSIT SCIENTIFIC
・TRISALUS LIFE SCIENCES, INC
（全165頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS AND EXCLUSIONS 24
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
・ FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION 25
・ FIGURE 2 MICROCATHETERS MARKET, BY REGION 25
1.3.2 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.2 RESEARCH DESIGN 28
・ FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN 28
2.2.1 SECONDARY DATA 29
2.2.2 PRIMARY DATA 29
・ FIGURE 4 PRIMARY SOURCES 29
2.2.2.1 KEY DATA FROM PRIMARY SOURCES 30
2.2.2.2 INSIGHTS FROM PRIMARY EXPERTS 30
・ FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 31
・ FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31
2.3 MARKET SIZE ESTIMATION 31
・ FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 32
・ FIGURE 8 TOP-DOWN APPROACH 33
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 35
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY 35
2.5 MARKET SHARE ESTIMATION 35
2.6 RESEARCH ASSUMPTIONS 36
2.7 STUDY LIMITATIONS 36
2.7.1 METHODOLOGY-RELATED LIMITATIONS 36
2.8 RISK ASSESSMENT 36
・ TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 36
3 EXECUTIVE SUMMARY 37
・ FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 37
・ FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION) 38
・ FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 38
・ FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 39
・ FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 39
4 PREMIUM INSIGHTS 41
4.1 MICROCATHETERS MARKET OVERVIEW 41
・ FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND 41
4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT 42
・ FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET 42
4.3 MICROCATHETERS MARKET SHARE, BY END USER 42
・ FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 42
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 43
・ FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 2022–2027 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
・ FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 44
5.2.1 DRIVERS 45
5.2.1.1 TECHNOLOGICAL ADVANCEMENTS IN INTERVENTIONAL CARDIOLOGY 45
5.2.1.2 EXPANSION OF PATIENT POPULATION SUFFERING FROM CHRONIC ILLNESS 45
5.2.1.3 INCREASING CONFERENCES AND SYMPOSIA TO SPREAD AWARENESS ABOUT BENEFITS OF MICROCATHETERS 45
5.2.2 RESTRAINTS 46
5.2.2.1 STRINGENT REGULATORY GUIDELINES AND HIGH COST OF DRUG APPROVAL 46
5.2.2.2 LACK OF AWARENESS ABOUT MICROCATHETERS IN UNDERDEVELOPED OR EMERGING COUNTRIES 46
5.2.3 OPPORTUNITIES 46
5.2.3.1 RISING NUMBER OF PATIENTS SUFFERING FROM CHRONIC DISEASES AND CANCER GLOBALLY 46
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 47
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 47
・ FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 47
・ TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET 47
5.4 PORTER’S FIVE FORCES ANALYSIS 47
5.4.1 OVERVIEW 47
・ TABLE 3 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 48
5.4.2 THREAT OF NEW ENTRANTS 48
5.4.3 THREAT OF SUBSTITUTES 48
5.4.4 BARGAINING POWER OF SUPPLIERS 48
5.4.5 BARGAINING POWER OF BUYERS 48
5.4.6 DEGREE OF COMPETITION 49
5.5 REGULATORY ANALYSIS 49
5.5.1 US 49
・ TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
5.5.2 EUROPE 50
5.5.3 JAPAN 50
・ TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 51
5.6 REIMBURSEMENT ANALYSIS 51
・ TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS 51
5.7 ECOSYSTEM ANALYSIS 52
5.8 VALUE CHAIN ANALYSIS 53
5.8.1 RESEARCH AND DEVELOPMENT 53
5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT 53
5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 53
・ FIGURE 21 VALUE CHAIN ANALYSIS 53
5.9 SUPPLY CHAIN ANALYSIS 54
5.9.1 PROMINENT COMPANIES 54
5.9.2 SMALL & MEDIUM-SIZED COMPANIES 54
5.9.3 END USERS 54
・ FIGURE 22 SUPPLY CHAIN ANALYSIS 54
5.10 PATENT ANALYSIS 54
5.11 TRADE ANALYSIS 55
・ TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55
・ TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION) 55
5.12 KEY CONFERENCES AND EVENTS IN 2022–2023 56
・ TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS 56
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 56
・ FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 57
6 MICROCATHETER MARKET, BY PRODUCT 58
6.1 INTRODUCTION 59
・ TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 59
・ TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
・ TABLE 12 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 60
・ TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 60
6.2 DELIVERY MICROCATHETERS 60
6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 60
・ TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 61
・ TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 61
・ TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62
・ TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 62
6.3 ASPIRATION MICROCATHETERS 63
6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET 63
・ TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 63
・ TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 63
・ TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64
・ TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 64
6.4 DIAGNOSTICS MICROCATHETERS 65
6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET 65
・ TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 65
・ TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 65
・ TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66
・ TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 66
6.5 STEERABLE MICROCATHETERS 67
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET 67
・ TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 67
・ TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 67
・ TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68
・ TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 68
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 69
7.1 INTRODUCTION 70
・ TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 70
7.2 SINGLE LUMEN MICROCATHETERS 70
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET 70
・ TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 71
7.3 DUAL-LUMEN MICROCATHETERS 71
7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET 71
・ TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 72
8 MICROCATHETERS MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
・ TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74
8.2 CARDIOVASCULAR APPLICATIONS 74
8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET 74
・ TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 75
8.3 NEUROVASCULAR APPLICATIONS 75
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 75
・ TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 76
8.4 PERIPHERAL VASCULAR APPLICATION 76
8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET 76
・ TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 77
8.5 ONCOLOGY APPLICATIONS 77
8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 77
・ TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 78
9 MICROCATHETERS MARKET, BY END USER 79
9.1 INTRODUCTION 80
・ TABLE 38 MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 80
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 80
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET 80
・ TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION) 81
9.3 AMBULATORY CARE CENTERS 81
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION 81
・ TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD MILLION) 82
10 MICROCATHETERS MARKET, BY REGION 83
10.1 INTRODUCTION 84
・ TABLE 41 MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 84
10.2 NORTH AMERICA 85
・ FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT 85
・ TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
・ TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 86
・ TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 86
・ TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
・ TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 87
10.2.1 US 88
10.2.1.1 US TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD 88
・ TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88
10.2.2 CANADA 88
10.2.2.1 INCREASING PREVALENCE OF TARGET DISEASES AND HIGH DEMAND FOR TIMELY DIAGNOSIS TO PROPEL MARKET 88
・ TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
10.3 EUROPE 89
・ TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
・ TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90
・ TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 90
・ TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90
・ TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 91
10.3.1 GERMANY 91
10.3.1.1 INCREASING AGING POPULATION AND RISING LIFE EXPECTANCY TO BOOST MARKET 91
・ TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91
10.3.2 FRANCE 92
10.3.2.1 SIGNIFICANT EVOLUTION OF HEALTHCARE SECTOR TO DRIVE MARKET 92
・ TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92
10.3.3 UK 92
10.3.3.1 HIGH BURDEN OF CHRONIC DISEASES AND LARGE VOLUME OF SURGERIES TO AUGMENT MARKET 92
・ TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93
10.3.4 ITALY 93
10.3.4.1 INCREASING GERIATRIC POPULATION TO AID GROWTH 93
・ TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93
10.3.5 SPAIN 93
10.3.5.1 INCREASING TECHNOLOGICAL DEVELOPMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET 93
・ TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
10.3.6 REST OF EUROPE 94
・ TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94
10.4 ASIA PACIFIC 95
・ FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT 95
・ TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
・ TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96
・ TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 96
・ TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97
・ TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 97
10.4.1 JAPAN 98
10.4.1.1 INCREASING GERIATRIC POPULATION AND SURGICAL PROCEDURES TO DRIVE MARKET 98
・ TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98
10.4.2 CHINA 99
10.4.2.1 GROWING PREVALENCE OF CHRONIC DISORDERS AND DEVELOPING HEALTHCARE INFRASTRUCTURE TO AID GROWTH 99
・ TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99
10.4.3 INDIA 100
10.4.3.1 INCREASING TARGET PATIENT POPULATION WITH RISING AVAILABILITY OF ADVANCED SURGICAL TREATMENTS TO DRIVE MARKET 100
・ TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 100
10.4.4 AUSTRALIA 100
10.4.4.1 DEVELOPING HEALTHCARE SECTOR AND INCREASING AVAILABILITY OF ADVANCED SURGICAL TREATMENTS TO STIMULATE MARKET 100
・ TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101
10.4.5 SOUTH KOREA 101
10.4.5.1 GROWING TARGET PATIENT POPULATION FOR CARDIOVASCULAR DISEASES TO DRIVE MARKET 101
・ TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101
10.4.6 REST OF ASIA PACIFIC 102
・ TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
10.5 LATIN AMERICA 102
10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET 102
・ TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
・ TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 103
・ TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 103
・ TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104
・ TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 104
10.6 MIDDLE EAST & AFRICA 105
10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET 105
・ TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
・ TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION) 106
・ TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
・ TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 106
11 COMPETITIVE LANDSCAPE 107
11.1 OVERVIEW 107
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 107
・ FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET 108
11.3 MARKET RANKING ANALYSIS 109
・ FIGURE 27 MICROCATHETERS MARKET (2021) 109
11.3.1 BOSTON SCIENTIFIC CORPORATION 109
11.3.2 ASAHI INTECC CO., LTD. 110
11.3.3 MEDTRONIC PLC 110
11.3.4 TELEFLEX 110
11.3.5 TERUMO MEDICAL CORPORATION 111
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 111
・ FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 111
11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 112
・ TABLE 80 OVERALL FOOTPRINT OF COMPANIES 112
・ TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES) 113
・ TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES) 114
・ TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES) 115
11.6 COMPANY EVALUATION QUADRANT 116
11.6.1 STARS 117
11.6.2 EMERGING LEADERS 117
11.6.3 PERVASIVE PLAYERS 117
11.6.4 PARTICIPANTS 117
・ FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 118
11.7 START-UPS/SMES EVALUATION QUADRANT 118
11.7.1 PROGRESSIVE COMPANIES 118
11.7.2 DYNAMIC COMPANIES 118
11.7.3 STARTING BLOCKS 119
11.7.4 RESPONSIVE COMPANIES 119
・ FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021) 119
11.8 COMPETITIVE SCENARIO 120
11.8.1 PRODUCT LAUNCHES AND APPROVALS 120
・ TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 2019–2022 120
11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 121
・ TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2022 121
12 COMPANY PROFILES 122
(BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESS/COMPETITIVE THREATS)*
12.1 KEY PLAYERS 122
12.1.1 BOSTON SCIENTIFIC CORPORATION 122
・ TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 122
・ FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021) 123
12.1.2 ASAHI INTECC CO., LTD. 125
・ TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW 125
・ FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021) 125
12.1.3 MEDTRONIC PLC 127
・ TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW 127
・ FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021) 128
12.1.4 STRYKER 130
・ TABLE 89 STRYKER: COMPANY OVERVIEW 130
・ FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021) 131
12.1.5 BECTON, DICKINSON AND COMPANY 133
・ TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 133
・ FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 134
12.1.6 TERUMO MEDICAL CORPORATION 136
・ TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 136
・ FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021) 137
12.1.7 MERIT MEDICAL SYSTEMS, INC. 139
・ TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 139
・ FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 140
12.1.8 CARDINAL HEALTH 142
・ TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW 142
・ FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 143
12.1.9 B. BRAUN MELSUNGEN AG 145
・ TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 145
12.1.10 COOK MEDICAL GROUP 147
・ TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW 147
12.1.11 TELEFLEX 150
・ TABLE 96 TELEFLEX: COMPANY OVERVIEW 150
12.1.12 JOHNSON & JOHNSON 151
・ TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW 151
12.1.13 ANGIODYNAMICS 152
・ TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW 152
12.1.14 PENUMBRA 153
・ TABLE 99 PENUMBRA: COMPANY OVERVIEW 153
12.1.15 BTG PLC 154
・ TABLE 100 BTG PLC: COMPANY OVERVIEW 154
12.1.16 GUERBET LLC 155
・ TABLE 101 GUERBET LLC: COMPANY OVERVIEW 155
12.1.17 EMBOLX INC. 156
・ TABLE 102 EMBOLX INC.: COMPANY OVERVIEW 156
12.1.18 TOKAI MEDICAL 157
・ TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW 157
12.1.19 KANEKA CORPORATION 158
・ TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT 158
12.1.20 INTEGER HOLDINGS CORPORATION 159
・ TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 159
12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD. 159
・ TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 159
12.1.22 MICROVENTION TERUMO 160
・ TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW 160
12.1.23 REFLOW MEDICAL 160
・ TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW 160
12.1.24 SPARTAN MICRO 161
・ TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW 161
12.1.25 TRANSIT SCIENTIFIC 161
・ TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW 161
12.1.26 TRISALUS LIFE SCIENCES, INC. 162
・ TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW 162
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, DEALS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESS/COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13 APPENDIX 163
13.1 DISCUSSION GUIDE 163
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166
13.3 CUSTOMIZATION OPTIONS 168
13.4 RELATED REPORTS 168
13.5 AUTHOR DETAILS 169